PT-141 (Bremelanotide) 10mg
PT-141 (Bremelanotide) 10mg Research Peptide
PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide with the structure Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH. This vial contains 10 mg of lyophilized bremelanotide, supplied as a reference material for in vitro laboratory research.
Intended for use by qualified researchers in controlled laboratory settings, for example as a reference standard in analytical method development, LC-MS identity work and in vitro assays.
Chemical identity
| Name | Bremelanotide |
|---|---|
| Synonyms | PT-141; PT141 |
| Structure (peptide notation) | Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH |
| Type | Cyclic heptapeptide with an N-terminal acetyl group and a free C-terminal acid |
| Non-standard residues | Norleucine (Nle) and D-phenylalanine (D-Phe) |
| CAS number | 189691-06-3 |
| Molecular formula | C50H68N14O10 |
| Average molecular weight | 1025.2 g/mol |
| Monoisotopic mass | 1024.52 Da |
Product specifications
| Form | Lyophilized powder |
|---|---|
| Appearance | White to off-white solid |
| Vial size | 10 mg per vial (nominal fill; net peptide content depends on salt form and counterion) |
| Storage (lyophilized) | Refrigerated in the closed vial, protected from moisture and light |
| Intended use | In vitro laboratory research only |
Structural notes
Bremelanotide is a head-to-side-chain cyclic peptide: the ring is closed by an amide (lactam) bond between the side chains of aspartic acid and lysine, as the cyclo(Asp…Lys) notation shows. The N-terminus carries an acetyl group and the C-terminus is a free carboxylic acid. It contains one norleucine, an unnatural residue, and one D-phenylalanine, and it includes a tryptophan residue, which is susceptible to oxidation.
Analytical identification
Expected masses for identity checks by LC-MS: 1025.2 Da average, 1024.52 Da monoisotopic (free base). The mass shifts if the material is supplied as a salt. Researchers should verify identity and purity of each lot with their own RP-HPLC and mass-spectrometry methods. This page does not state a purity figure.
Handling and storage
Store the lyophilized powder refrigerated in the original closed vial, protected from light and moisture. Allow the vial to reach room temperature before opening to limit condensation. Because of the tryptophan residue, limit exposure to light, air and oxidizing conditions. Avoid repeated freeze–thaw cycles of any prepared solution, and follow your laboratory’s own procedures.
Research use only
For laboratory research use only. Not for human or veterinary use. Not a drug, food, dietary supplement or cosmetic, and not intended for diagnostic or therapeutic use. Not an FDA-approved drug product. No dosing, reconstitution or usage information for people or animals is provided. Buyers must be qualified researchers and are responsible for compliance with all applicable laws.
Frequently asked questions
What is PT-141?
PT-141 is another name for bremelanotide, a synthetic cyclic heptapeptide. This product is a research material for in vitro laboratory work.
What is the structure of bremelanotide?
Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH: an acetylated, cyclic heptapeptide with a lactam bridge between the aspartic acid and lysine side chains and a free C-terminal acid.
What are the CAS number and molecular weight of PT-141?
CAS 189691-06-3, molecular formula C50H68N14O10, average molecular weight 1025.2 g/mol (monoisotopic 1024.52 Da), for the free base.
What form and size is this product?
A lyophilized powder with a nominal fill of 10 mg per vial. Net peptide content depends on the salt form and counterion.
How should PT-141 be stored?
Store the lyophilized powder refrigerated in the closed vial, away from light and moisture, and let it reach room temperature before opening.
Do you provide dosing or reconstitution instructions?
No. This product is sold for in vitro laboratory research only, and no dosing, reconstitution or usage instructions are provided.
Is this the approved prescription drug?
No. A prescription product containing bremelanotide (Vyleesi) is approved by the FDA. This product is a research material. It is not that drug, it has not been evaluated by the FDA for any use, and it is sold for in vitro research only.
Can this product be used in people or animals?
No. It is for laboratory research use only and is not for human or veterinary use.
Research Use Disclaimer
Legal Notice
Products provided by Peptide Biogenix are intended exclusively for laboratory research and scientific development. They are not approved for human or veterinary use.
Purchaser Responsibility
By placing an order, you acknowledge responsibility for the lawful handling, storage, and use of all research materials in accordance with applicable regulations.
